SANTARUS
Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. The company's current commercial efforts are focused on five products. UCERIS® (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis and ZEGERID® (omeprazole/sodium bicarbonate) for the treatment of certain upper gastrointestinal disorders are promoted to gastroenterologists.
SANTARUS
Industry:
Biopharma Biotechnology Health Care
Founded:
1996-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.santarus.com
Total Employee:
501+
Status:
Active
Contact:
8583145705
Email Addresses:
[email protected]
Total Funding:
89.4 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS GoDaddy SSL Salesforce SPF MarkMonitor DNS Dyn Hosting
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
![]()
![]()
Current Employees Featured

Founder
![]()
Stock Details
Investors List
![]()
New England Partners
New England Partners investment in Series D - Santarus
![]()
JPMorgan Partners
JPMorgan Partners investment in Series D - Santarus
Advent Venture Partners
Advent Venture Partners investment in Series D - Santarus
![]()
St. Paul Venture Capital
St. Paul Venture Capital investment in Series D - Santarus
![]()
China Development Industrial Bank (CDIB)
China Development Industrial Bank (CDIB) investment in Series D - Santarus
Life Sciences Partners
Life Sciences Partners investment in Series D - Santarus
![]()
Windamere Venture Partners
Windamere Venture Partners investment in Series D - Santarus
![]()
Domain Associates
Domain Associates investment in Series D - Santarus
![]()
Fog City Capital
Fog City Capital investment in Series D - Santarus
Advent Venture Partners
Advent Venture Partners investment in Series C - Santarus
Official Site Inspections
http://www.santarus.com
- Host name: aeedc42b70c898c66.awsglobalaccelerator.com
- IP address: 3.33.139.32
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
